TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Nordic Biomarker AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 (consolidated) |
Turnover |
123,929
|
122,616
|
127,502 |
Financial expenses |
2,055
|
1,706
|
381 |
Earnings before taxes |
-41,254
|
-23,942
|
-10 |
EBITDA |
-27,455
|
-13,672
|
11,699 |
Total assets |
165,462
|
196,843
|
169,523 |
Current assets |
70,181
|
67,173
|
71,387 |
Current liabilities |
81,350
|
67,309
|
35,925 |
Equity capital |
76,442
|
127,975
|
96,748 |
- share capital |
152
|
142
|
146 |
Employees (average) |
69
|
75
|
66 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 (consolidated) |
Solvency |
46.2%
|
65.0%
|
57.1% |
Turnover per employee |
1,796
|
1,635
|
1,932 |
Profit as a percentage of turnover |
-33.3%
|
-19.5%
|
0.0% |
Return on assets (ROA) |
-23.7%
|
-11.3%
|
0.2% |
Current ratio |
86.3%
|
99.8%
|
198.7% |
Return on equity (ROE) |
-54.0%
|
-18.7%
|
0.0% |
Change turnover |
-7,387
|
-1,054
|
21,255 |
Change turnover % | -6% | 20% | |
Chg. No. of employees |
-6
|
9
|
10 |
Chg. No. of employees % | -8% | 18% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.